檢索結果 - Lang, Chim C

Non‐cardiac comorbidities in chronic heart failure 由 Lang, Chim C, Mancini, Donna M

獲取全文 獲取全文 獲取全文

Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond 由 Singh, Jagdeep SS, Lang, Chim C

獲取全文 獲取全文 獲取全文

Targeting Metabolic Modulation and Mitochondrial Dysfunction in the Treatment of Heart Failure 由 Steggall, Abbey, Mordi, Ify R., Lang, Chim C.

獲取全文 獲取全文 獲取全文

Iron Therapy in Heart Failure: Ready for Primetime? 由 Mordi, Ify R, Tee, Aaron, Lang, Chim C

獲取全文 獲取全文 獲取全文

What is the added value of the waist‐to‐hip ratio on top of the BIOSTAT risk prediction model in patients with heart failure? Reply 由 Streng, Koen W., Lang, Chim C., Voors, Adriaan A.

獲取全文 獲取全文 獲取全文

Pulmonary Arterial Hypertension: Pathophysiology and Treatment 由 Lan, Norris S. H., Massam, Benjamin D., Kulkarni, Sandeep S., Lang, Chim C.

獲取全文 獲取全文 獲取全文

Nicorandil‐induced colovesical fistula in a patient with diverticular disease 由 Noyes, James D., Mordi, Ify R., Zeb, Qaiser, Lang, Chim C.

獲取全文 獲取全文 獲取全文

Cardiotoxicity and Chemotherapy—The Role of Precision Medicine 由 Viswanathan, Thyla, Lang, Chim C., Petty, Russell D., Baxter, Mark A.

獲取全文 獲取全文 獲取全文

AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease 由 Wong, Aaron K. F., Howie, Jacqueline, Petrie, John R., Lang, Chim C.

獲取全文 獲取全文 獲取全文

Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial 由 Noman, Awsan, Ang, Donald SC, Ogston, Simon, Lang, Chim C, Struthers, Allan D

獲取全文 獲取全文 獲取全文

Precision Medicine and Adverse Drug Reactions Related to Cardiovascular Drugs † 由 Noyes, James D., Mordi, Ify R., Doney, Alexander S., Jamal, Rahman, Lang, Chim C.

獲取全文 獲取全文 獲取全文

Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects 由 Yang, Y S, Wong, L P, Lee, T C, Mustafa, A M, Mohamed, Z, Lang, Chim C

獲取全文 獲取全文 獲取全文

Differential Association of Genetic Risk of Coronary Artery Disease with Development of Heart Failure with Reduced Versus Preserved Ejection Fraction: A GoDARTS Mendelian Randomiza... 由 Mordi, Ify R, Pearson, Ewan R, Palmer, Colin NA, Doney, Alexander SF, Lang, Chim C

獲取全文 獲取全文 獲取全文

Use of Population-Based Health Informatics Research to Improve Care for Patients with Cardiovascular Diseases 由 Mordi, Ify R., Guignard-Duff, Magalie, Hall, Christopher, New, Benjamin Jaa Ming, Lang, Chim C.

獲取全文 獲取全文 獲取全文

Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention 由 Mohan, Mohapradeep, Dihoum, Adel, Mordi, Ify R., Choy, Anna-Maria, Rena, Graham, Lang, Chim C.

獲取全文 獲取全文 獲取全文

Resting Heart Rate and Outcomes in Patients with Cardiovascular Disease: Where Do We Currently Stand? 由 Menown, Ian BA, Davies, Simon, Gupta, Sandeep, Kalra, Paul R, Lang, Chim C, Morley, Chris, Padmanabhan, Sandosh

獲取全文 獲取全文 獲取全文

Differential effects of carvedilol and atenolol on plasma noradrenaline during exercise in humans 由 Herman, Rahmatina B, Jesudason, Peter J, Mustafa, Ali M, Husain, Ruby, Choy, Anna Maria J, Lang, Chim C

獲取全文 獲取全文 獲取全文

Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure: The RECEDE-CHF Trial 由 Mordi, Natalie A., Mordi, Ify R., Singh, Jagdeep S., McCrimmon, Rory J., Struthers, Allan D., Lang, Chim C.

獲取全文 獲取全文 獲取全文

A randomized controlled trial of dapagliflozin on left ventricular hypertrophy in people with type two diabetes: the DAPA-LVH trial 由 Brown, Alexander J M, Gandy, Stephen, McCrimmon, Rory, Houston, John Graeme, Struthers, Allan D, Lang, Chim C

獲取全文 獲取全文 獲取全文

Microvascular disease and heart failure with reduced and preserved ejection fraction in type 2 diabetes 由 Mordi, Ify R., Tee, Aaron, Palmer, Colin N., McCrimmon, Rory J., Doney, Alexander S.F., Lang, Chim C.

獲取全文 獲取全文 獲取全文